18:06:36 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-05 Kvartalsrapport 2024-Q3
2024-08-06 Kvartalsrapport 2024-Q2
2024-05-07 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning CRBX 0.00 SEK
2024-04-26 Årsstämma 2024
2024-02-16 Bokslutskommuniké 2023
2024-01-10 Extra Bolagsstämma 2024
2023-11-07 Kvartalsrapport 2023-Q3
2023-08-08 Kvartalsrapport 2023-Q2
2023-05-09 Kvartalsrapport 2023-Q1
2023-04-24 Ordinarie utdelning CRBX 0.00 SEK
2023-04-21 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-08 Kvartalsrapport 2022-Q3
2022-08-09 Kvartalsrapport 2022-Q2
2022-05-10 Kvartalsrapport 2022-Q1
2022-04-25 Ordinarie utdelning CRBX 0.00 SEK
2022-04-22 Årsstämma 2022
2022-02-18 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-10 Kvartalsrapport 2021-Q2
2021-05-11 Kvartalsrapport 2021-Q1
2021-04-26 Ordinarie utdelning CRBX 0.00 SEK
2021-04-23 Årsstämma 2021
2021-02-18 Bokslutskommuniké 2020
2020-11-10 Kvartalsrapport 2020-Q3
2020-08-11 Kvartalsrapport 2020-Q2
2020-05-12 Kvartalsrapport 2020-Q1
2020-04-27 Ordinarie utdelning CRBX 0.00 SEK
2020-04-24 Årsstämma 2020
2020-02-12 Bokslutskommuniké 2019
2019-11-14 Kvartalsrapport 2019-Q3

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriLäkemedel & Handel
Carbiotix är ett bioteknikföretag verksamma inom mikrobiomområdet. Företaget bedriver idag forskning och utveckling samt säljer produkter och tjänster inom primärt fyra affärsområden: Diagnostik av tarmhälsa, prebiotiska ingredienser, medicinsk mat och terapeutiska behandlingar. Bolaget grundades under 2014 och har sitt huvudkontor i Lund.
2022-04-11 08:45:00

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company CEO Kristofer Cook has purchased Carbiotix shares for SEK 450,000 between March 25 and April 8 through his holding company Sustainable Holding Sweden AB and has pre-subscribed to purchase a further 550,000 SEK in the proposed rights issue scheduled for the second quarter of 2022. Kristofer Cook has thereby committed to share purchases totaling SEK 1 million before and including the planned rights issue. Kristofer Cook's total holding before the latest acquisition was 2 410 000 shares, corresponding to 19.54 percent. After the acquisition, the holding amounts to 2,448,528 shares, corresponding to approximately 19.85 percent of the voting rights and capital of the Company.

Kristofer Cook, CEO of Carbiotix, comments
"A decision to increase my position in Carbiotix reflects my continued and growing faith in the Company, especially in light of our recent progress moving towards the commercialisation of our first CarbiAXOS product and the interest shown in the market. The 550,000 SEK pre-subscription is part of the SEK 1 million pre-subscribed by Carbiotix management team and Board that was previously communicated.

The Swedish article is available via the following link: Carbiotix sammanfattar aktiviteter under Q1 - positiva framsteg och intresse för CarbiAXOS - Carbiotix (https://news.cision.com/se/carbiotix/r/carbiotix-sammanfattar-aktiviteter-under-q1---positiva-framsteg-och-intresse-for-carbiaxos,c3541659) (cision.com)

Forward-looking statements
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.